Chemed Corporation CHE
533.77 USD -14.87 (-2.71%)
At closeNov 5, 2026, 5:30 PM EST
533.77 0.00 0.00%
After hours · Nov 5, 5:30 PM ET
528.82 Day range 557.64
365.21 52-week range 562.24
- YTD
- +24.75%
- 1 year
- +21.59%
- Market cap
- 6.92B
- Revenue (ttm)
- 2.66B
- Profit margin
- 10.61%
- EPS (ttm)
- 20.31
- Shares out
- 12.96M
- P/E ratio
- 26.28
- Forward P/E
- 19.18
- Dividend
- 2.80 (0.52%)
- Ex-dividend date
- Aug 16, 2026
- YTD return
- +24.75%
- 1-year return
- +21.59%
- Volume
- 137.38K
- Avg volume
- 152.94K
- Open
- 555.50
- Previous close
- 548.64
- Day's range
- 528.82 – 557.64
- 52-week range
- 365.21 – 562.24
- Beta
- 0.49
- Analysts
- Buy
- Price target
- 617.00 (+15.6%)
- Earnings date
- Feb 24, 2027
5D -14.66 (-2.67%)
Key statistics
- Enterprise value
- 7.45B
- PEG ratio
- 1.91
- Price / sales
- 2.60
- Price / book
- 8.04
- Dividend yield
- 0.51%
- Payout ratio
- 11.97%
- Revenue growth
- 10.60%
- Free cash flow
- 265.51M
- Total cash
- 48.43M
- Total debt
- 392.19M
- Return on equity
- 29.14%
- Short % of float
- 6.24%
- 50-day average
- 514.71
- 200-day average
- 464.08
Analyst view
Consensus: buy
Buy
Price target (mean) 617.00 +15.6% upside
Now 533.77
- Target (low)
- 580.00
- Target (mean)
- 617.00
- Target (high)
- 675.00
Ratings (0m) 5 3 buy · 2 hold · 0 sell
- Strong buy0
- Buy3
- Hold2
- Sell0
- Strong sell0
Next earnings
Feb 24, 2027
Expected Feb 24, 2027. Consensus EPS estimate 7.35.
Financials — quick view
CHE Revenue — quarterly 690.94M
CHE Net income — quarterly 71.65M
CHE EPS — quarterly 5.49
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 24, 2027 | Dec 30, 2026 | 7.32 | — | — | — |
| Oct 27, 2026 | Sep 30, 2026 | 6.44 | 6.75 | +0.31 | +4.81% |
| Jul 28, 2026 | Jun 30, 2026 | 5.60 | 6.06 | +0.46 | +8.21% |
| Apr 23, 2026 | Mar 31, 2026 | 5.30 | 5.65 | +0.35 | +6.60% |
| Feb 25, 2026 | Dec 31, 2025 | 7.02 | 6.42 | -0.60 | -8.55% |
| Oct 28, 2025 | Sep 30, 2025 | 5.39 | 5.27 | -0.12 | -2.23% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 29, 2026 | RBC Capital | main | Sector Perform | Sector Perform |
| Oct 29, 2026 | UBS | main | Buy | Buy |
| Oct 29, 2026 | Oppenheimer | main | Outperform | Outperform |
| Oct 28, 2026 | Jefferies | up | Hold | Buy |
| Sep 25, 2026 | UBS | init | — | Buy |
| Jul 31, 2026 | Oppenheimer | main | Outperform | Outperform |
About Chemed Corporation
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, doctors, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates through two segments: VITAS and Roto-Rooter segments. The company offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company also provides direct medical services to patients, as well as spiritual and emotional counseling to both patients and their families. Chemed Corporation was incorporated in 1970 and is headquartered in Cincinnati, Ohio.
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Country
- United States
- Website
- chemed.com
News
Why Chemed (CHE) is a Top Value Stock for the Long-Term 
Chemed Corporation to Present at the UBS 2026 Global Healthcare Conference 
RBC Capital Maintains Sector Perform on Chemed, Raises Price Target to $585 
Oppenheimer Maintains Outperform on Chemed, Raises Price Target to $625 
What Chemed (CHE) Said on Its Q3 Earnings Call 
Jefferies Upgrades Chemed to Buy, Raises Price Target to $620 
Chemed Corporation (CHE) Q3 2026 Earnings Call Transcript 
Chemed Q3 2026 Earnings Call Transcript 
Here Are Wednesday’s Top Wall Street Analyst Research Calls: Enphase Energy, F5, Marvell Technology, MSG Rangers, Pentair, Silicon Motion Technology, Spotify Technology, Texas Instruments, Whirlpool, and More 
Chemed (CHE) Tops Q3 Earnings and Revenue Estimates
Your note
Sign in to keep a note on CHE — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| DELYONS RON | Director | Stock Award(Grant) | May 17, 2026 | 2,052 |
| GRACE PATRICK P | Director | Sale | Jul 30, 2026 | 3,533 |
| HEANEY CHRISTOPHER J | Director | Stock Award(Grant) | May 17, 2026 | 2,775 |
| HUTTON THOMAS CHARLES | Officer and Director | Conversion of Exercise of derivative security | Sep 27, 2026 | 32,840 |
| JUDKINS BRIAN C | Officer | Conversion of Exercise of derivative security | Aug 9, 2026 | 3,344 |
| LEE SPENCER S | Officer | Sale | Nov 1, 2026 | 13,931 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 11.40% | 1,484,282 | 792.93M | Jun 29, 2026 |
| AQR Capital Management, LLC | 7.47% | 972,474 | 519.52M | Jun 29, 2026 |
| Vanguard Portfolio Management LLC | 6.05% | 787,068 | 420.47M | Jun 29, 2026 |
| Vanguard Capital Management LLC | 4.64% | 604,420 | 322.89M | Jun 29, 2026 |
| Acadian Asset Management. LLC | 3.48% | 453,238 | 242.13M | Jun 29, 2026 |
| State Street Corporation | 3.42% | 444,716 | 237.58M | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| iShares Trust-iShares Core S&P Mid-Cap ETF | 3.58% | 465,608 | 248.74M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.27% | 426,035 | 227.60M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 2.36% | 307,739 | 164.40M | Jun 29, 2026 |
| John Hancock Funds III-Disciplined Value Mid Cap Fund | 1.94% | 251,878 | 134.56M | Sep 29, 2026 |
| Capitol Series Trust-FullerThaler Behavioral Small-Cap Equity Fund | 1.62% | 210,584 | 112.50M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Growth Index Fund | 1.36% | 176,971 | 94.54M | Jun 29, 2026 |